Timothy Curran, DPM
Surgery · Abington, MANPI 1063447597
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Kairos Surgical Inc at 49.6% of the total. Reporting peaked in 2019 at $2,722 and has fallen 94.2% since, to $158 in 2025.
Across 48 payments — averaging $127.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$3K
- Zimmer Biomet$1K
- Arthrex$462
- Smith+Nephew$261
- Organogenesis Inc.$261
- Silk Road Medical, Inc.$185
- plus $535 from 11 others
What the payments were for
- Travel & lodging$2,23636%
- Food & beverage$1,40623%
- Education$2,49141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 6 | $3,041 |
| Zimmer Biomet | 5 | $1,387 |
| Arthrex | 4 | $462 |
| Smith+Nephew | 8 | $261 |
| Organogenesis Inc. | 5 | $261 |
| Silk Road Medical, Inc. | 1 | $185 |
| Stryker | 3 | $152 |
| Acera Surgical, Inc. | 3 | $71 |
| Pfizer | 2 | $65 |
| Orthofix Medical, Inc. | 3 | $50 |
| Aroa Biosurgery Incorporated | 1 | $42 |
| Medtronic | 2 | $39 |
| Tactile Systems Technology Inc | 1 | $30 |
| Boston Scientific | 1 | $27 |
| AbbVie | 1 | $24 |
| Solventum Corporation | 1 | $20 |
| Sanara Medtech Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,133 in reported general payments places this provider in the 75th percentile of 694 surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 26 | $35,340 |
| OxycontinOxycodone Hcl | 12 | $18,100 |
| Ketoconazole | 155 | $4,298 |
| Diclofenac Sodium | 50 | $2,281 |
| Ciclopirox | 71 | $2,033 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 65 | $1,620 |
| Betamethasone Dipropionate | 29 | $1,300 |
| Ammonium Lactate | 55 | $1,226 |
| Terbinafine Hcl | 38 | $345 |
| Sulindac | 14 | $114 |
| Triamcinolone Acetonide | 11 | $81 |
| Oxycodone Hcl | 26 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgery in Abington
- Michael TarnoffBoston$1.4M
- Omar KudsiBoston$886K
- Philip CohenBrockton$280K
- Ankit MehtaBoston$278K
- Mark ConradMethuen$187K
- James HermenegildoFall River$178K
- Richard EngelmanSpringfield$167K
- Reuben ShinBurlington$158K
- Richard BirkettBeverly$93K
- Johannes KratzBoston$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.